JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) — Capital Reinvestment Ratio

Latest as of June 2025: 0.40x

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a Capital Reinvestment Ratio of 0.40x as of June 2025, meaning it reinvests 0% of its operating cash flow ($2.56 Million) in capital expenditures ($1.03 Million). See how much free cash does JIN MEDICAL INTERNATIONAL LTD. Ordinary generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.40x
Capex / Operating Cash Flow

Operating Cash Flow

$2.56 Million
USD

Capital Expenditures

$1.03 Million
USD

Data as of

Jun 2025
Most recent filing

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Capital Reinvestment Ratio (2020–2025)

This chart tracks JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's Capital Reinvestment Ratio across 5 annual periods.

Annual Capital Reinvestment Ratio for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2020–2025)

Year-by-year Capital Reinvestment Ratio for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2020 to 2025. For live market cap and broader valuation context, see ZJYL market cap.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 2.28x $2.90 Million $6.63 Million ▲ +6125.3%
2023 0.04x $3.11 Million $113.94K ▲ +44.3%
2022 0.03x $1.58 Million $40.17K ▲ +246.3%
2021 0.01x $5.84 Million $42.88K ▼ -87.1%
2020 0.06x $2.50 Million $142.32K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow